Mirae Asset Global Investments Co., Ltd. Nkarta, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$5.59 - $15.71 $75,414 - $211,943	13,491 New	13,491 $145,000
Q2 2023 Aug 10, 2023	SELL	$2.19 - $5.17 $214 - $506	-98 Reduced 0.67%	14,597 $31,000
Q1 2023 May 04, 2023	SELL	$3.37 - $6.3 $104 - $195	-31 Reduced 0.21%	14,695 $52,000
Q4 2022 Feb 09, 2023	BUY	$5.14 - $14.35 $107 - $301	21 Added 0.14%	14,726 $88,000
Q3 2022 Nov 10, 2022	BUY	$12.27 - $18.39 $49,803 - $74,645	4,059 Added 38.13%	14,705 $194,000
Q2 2022 Jul 26, 2022	BUY	$7.77 - $19.44 $82,719 - $206,958	10,646 New	10,646 $131,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.